Are we headed for a repeat of 2022’s brutal selloff? While no one can predict the future with certainty, current market trends are raising some ominous red flags. After a meteoric rally fueled by the AI craze, many investors seem to be taking profits off the table. And who can blame them? The surge we’ve witnessed is eerily reminiscent of the 2021 rally.And let’s not forget the potential domino effect for certain sectors. With tech and AI stocks commanding such hefty weightings in the major indexes, a sello ...

Cardinal Health (CAH) ended the recent trading session at $103.37, demonstrating a +0.53% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.2%. Elsewhere, the Dow saw an upswing of 0.69%, while the tech-heavy Nasdaq appreciated by 1.59%.The the stock of prescription drug distributor has fallen by 7.37% in the past month, lagging the Medical sector's loss of 5.82% and the S&P 500's loss of 4.16%.The investment community will be closely monitoring the ...

Cardinal Health (CAH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this prescription drug distributor have returned -7.4%, compared to the Zacks S&P 500 composite's -4.2% change. During this period, the Zacks Medical - Dental Supplies industry, which Cardinal falls in, has lost 4.2%. The key question now is: What could be the stock's future direction?W ...

DUBLIN, Ohio, April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35. Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and Specialty Solutions long-term segment profit CAGR target of 4% to 6% and its consolidated non-GAAP EPS CAGR ta ...

champpixs CAH is overvalued Cardinal Health (NYSE:CAH) caught our attention recently when we were screening for stocks with yields noticeably outside their normal range. And CAH really caught our attention because its dividend yield is currently way out of its historical range. As you can clearly see from the charts below, its current yield of 1.88% is among the lowest levels in at least 5 years. It is lower than its 5-year average yield of 3.25% by a whopping 42%, implying substantial overvaluation. Other ...

Cardinal Health (CAH) closed the most recent trading day at $107.03, moving +1.84% from the previous trading session. This move outpaced the S&P 500's daily loss of 1.2%. Meanwhile, the Dow experienced a drop of 0.65%, and the technology-dominated Nasdaq saw a decrease of 1.79%.The prescription drug distributor's stock has dropped by 4.98% in the past month, exceeding the Medical sector's loss of 6.57% and lagging the S&P 500's loss of 0.85%.Market participants will be closely following the financial result ...

CPI, the Consumer Price Index, is a metric used to gauge the rate of inflation and deflation. It’s released by the Bureau of Labor Statistics (BLS) and reports the monthly fluctuations in consumer goods and services prices.The CPI is a market-moving metric in that when it shows a deflation rate compared to the previous year, the market tends to react positively. On the other side, if it’s reported that inflation rose compared to the year before, this can negatively affect investors.The Consumer Price Index ...

Cardinal Health (CAH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this prescription drug distributor have returned -3.2%, compared to the Zacks S&P 500 composite's +1.6% change. During this period, the Zacks Medical - Dental Supplies industry, which Cardinal falls in, has lost 0.4%. The key question now is: What could be the stock ...

Cardinal Health (CAH) closed the most recent trading day at $109.47, moving -0.41% from the previous trading session. This change lagged the S&P 500's 0.04% loss on the day. Meanwhile, the Dow lost 0.03%, and the Nasdaq, a tech-heavy index, added 0.03%.Heading into today, shares of the prescription drug distributor had lost 4.56% over the past month, lagging the Medical sector's loss of 0.6% and the S&P 500's gain of 2.57% in that time.The investment community will be closely monitoring the performance of C ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Cardinal Health (CAH) , which belongs to the Zacks Medical - Dental Supplies industry, could be a great candidate to consider.When looking at the last two reports, this prescription drug distributor has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 20.12%, on average, in the last two quarters.For the las ...